Isracann Completes Executive Site and Prospect Visit in Israel
27. Februar 2020 09:00 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a...
Isracann Receives Project Characterization Report and Engages EU GMP Consultancy
09. Januar 2020 00:05 ET
|
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a...